UNIGE document Master
previous document  unige:16153  next document
add to browser collection

Développement d’un gel oestrogénique transdermique pour un traitement hormonale substitutif

Denomination Maîtrise Universitaire en Pharmacie
Defense Maîtrise : Univ. Genève, 2011
Abstract Estrogen replacement therapy is gaining importance for treating the most common symptoms of estrogen decline in menopausal hysterectomized women: vasomotor symptoms, urogenital atrophy, and bone loss. However, cardiovascular safety concerns (Women’s Health Initiative trial) and increased breast cancer risk (Million Women Study) have dramatically reduced oral treatment of the condition. The need of alternative, safer routes of estradiol administration is therefore recognized by the medical community. The aim of this project is to develop an effective, safe, and cosmetically acceptable gel for the systemic delivery of estradiol.
Keywords Transdermal deliveryEstradiolEstrogen replacement therapyTransdermal gel
Stable URL https://archive-ouverte.unige.ch/unige:16153
Full text
Master (1.3 MB) - document accessible for UNIGE members only Limited access to UNIGE

215 hits



Deposited on : 2011-06-14

Export document
Format :
Citation style :